Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUMONA BHATTACHARYA

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1598210973
CMS profile
11306752
Location
WASHINGTON, DC

General Payments · PY2021–2024

$85,001.57

  • Reported across 115 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,768.92

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,605.00 1
Food and Beverage $1,163.92 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Scientific Affairs, LLC $1,865.36 3
ABBVIE INC. $253.77 12
Janssen Biotech, Inc. $217.21 8
PFIZER INC. $161.47 3
Takeda Pharmaceuticals U.S.A., Inc. $83.53 4
AIMMUNE THERAPEUTICS, INC. $64.40 3
Lilly USA, LLC $52.59 2
Celgene Corporation $50.00 1
GENZYME CORPORATION $20.59 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $40,204.00 1
PY2022 $40,434.18 21
PY2023 $1,594.47 56
PY2024 $2,768.92 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.95 01/30/2024 Food and Beverage Undisputed 01/23/2026 1103322734 CMS
ABBVIE INC. $31.76 02/07/2024 Food and Beverage Undisputed 01/23/2026 1103322736 CMS
ABBVIE INC. $21.04 02/23/2024 Food and Beverage Undisputed 01/23/2026 1103322738 CMS
ABBVIE INC. $22.05 03/23/2024 Food and Beverage Undisputed 01/23/2026 1103322740 CMS
ABBVIE INC. $21.52 05/10/2024 Food and Beverage Undisputed 01/23/2026 1103322742 CMS
ABBVIE INC. $22.07 06/04/2024 Food and Beverage Undisputed 01/23/2026 1103322744 CMS
ABBVIE INC. $26.71 06/06/2024 Food and Beverage Undisputed 01/23/2026 1103322746 CMS
ABBVIE INC. $20.03 07/19/2024 Food and Beverage Undisputed 01/23/2026 1103322748 CMS
ABBVIE INC. $22.32 08/06/2024 Food and Beverage Undisputed 01/23/2026 1103322750 CMS
ABBVIE INC. $23.71 11/22/2024 Food and Beverage Undisputed 01/23/2026 1103322752 CMS
ABBVIE INC. $1.43 11/23/2024 Food and Beverage Undisputed 01/23/2026 1103322754 CMS
ABBVIE INC. $22.18 12/12/2024 Food and Beverage Undisputed 01/23/2026 1103322756 CMS
AIMMUNE THERAPEUTICS, INC. $22.44 04/19/2024 Food and Beverage Undisputed 01/23/2026 1146964992 CMS
AIMMUNE THERAPEUTICS, INC. $22.44 04/19/2024 Food and Beverage Undisputed 01/23/2026 1146984117 CMS
AIMMUNE THERAPEUTICS, INC. $19.52 06/29/2024 Food and Beverage Undisputed 01/23/2026 1146985411 CMS
Celgene Corporation $50.00 07/10/2024 Food and Beverage Undisputed 01/23/2026 1101191539 CMS
GENZYME CORPORATION $20.59 01/09/2024 Food and Beverage Undisputed 01/23/2026 1139735244 CMS
Janssen Biotech, Inc. $27.74 01/11/2024 Food and Beverage Undisputed 01/23/2026 1078390162 CMS
Janssen Biotech, Inc. $24.68 03/18/2024 Food and Beverage Undisputed 01/23/2026 1078390522 CMS
Janssen Biotech, Inc. $25.89 04/23/2024 Food and Beverage Undisputed 01/23/2026 1078390506 CMS
Janssen Biotech, Inc. $22.86 04/30/2024 Food and Beverage Undisputed 01/23/2026 1078389848 CMS
Janssen Biotech, Inc. $21.99 07/16/2024 Food and Beverage Undisputed 01/23/2026 1078390110 CMS
Janssen Biotech, Inc. $33.05 08/13/2024 Food and Beverage Undisputed 01/23/2026 1078391501 CMS
Janssen Biotech, Inc. $29.78 12/03/2024 Food and Beverage Undisputed 01/23/2026 1078391172 CMS
Janssen Biotech, Inc. $31.22 12/13/2024 Food and Beverage Undisputed 01/23/2026 1078390668 CMS
Janssen Scientific Affairs, LLC $131.27 01/18/2024 Food and Beverage Undisputed 01/23/2026 1078846653 CMS
Janssen Scientific Affairs, LLC $129.09 05/17/2024 Food and Beverage Undisputed 01/23/2026 1078846603 CMS
Janssen Scientific Affairs, LLC $1,605.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 1078846607 CMS
Lilly USA, LLC $20.99 03/28/2024 Food and Beverage Undisputed 01/23/2026 1135351481 CMS
Lilly USA, LLC $31.60 11/26/2024 Food and Beverage Undisputed 01/23/2026 1135420061 CMS
PFIZER INC. $22.67 02/20/2024 Food and Beverage Undisputed 01/23/2026 1131196659 CMS
PFIZER INC. $114.66 04/18/2024 Food and Beverage Undisputed 01/23/2026 1131568545 CMS
PFIZER INC. $24.14 12/10/2024 Food and Beverage Undisputed 01/23/2026 1131168805 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.30 02/28/2024 Food and Beverage Undisputed 01/23/2026 1137488385 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.19 04/19/2024 Food and Beverage Undisputed 01/23/2026 1137488389 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.06 07/18/2024 Food and Beverage Undisputed 01/23/2026 1137488393 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.98 12/05/2024 Food and Beverage Undisputed 01/23/2026 1137488397 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.